PedAM
Pediatric Disease Annotations & Medicines
| Disease | graft-vs-host disease |
| Phenotype | C0026986|myelodysplastic syndromes |
| Sentences | 1 |
| PubMedID- 22952334 | Lenalidomide maintenance after allogeneic hsct seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the lenamaint trial. |
Page: 1